ANDERSEN ERIC purchased 108.4% of their position (221.55K shares) of MERRIMACK PHARMACEUTICALS INC on the open market
Open‑market purchase worth $2.66M — a major conviction buy. The strongest form of insider conviction signal.
P · 4 purchases
Filed: 8/9/2023ACC: 0000950170-23-040559
DirectorOther
Since Sep 2019
+221.55K
Net shares
Net buyer
$2.66M
Total acquired
4
Open market trades
4B · 0S
4
Total transactions
221.55K acquired
Non-Derivative Transactions4
Common Stock
Indirect
Shares
+84.64K
Price / share
$12.00
Trade value
$1.02M
% of position
6.0%
8/7/2023
1.41M→1.50M
Common Stock
Indirect
Shares
+49.86K
Price / share
$12.00
Trade value
$598.47K
% of position
13.9%
8/7/2023
357.51K→407.37K
Common Stock
Indirect
Shares
+68.43K
Price / share
$12.00
Trade value
$820.89K
% of position
4.6%
8/8/2023
1.50M→1.57M
Common Stock
Indirect
Shares
+18.63K
Price / share
$12.00
Trade value
$223.44K
% of position
4.6%
8/8/2023
407.37K→426K
Total
Net shares
+221.55K
Net value
$2.66M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 8/7/2023 | P · Purchase | +84.64K | $12.00 | $1.02M | 6.0% | 1.41M | 1.50M |
| Common Stock Indirect | 8/7/2023 | P · Purchase | +49.86K | $12.00 | $598.47K | 13.9% | 357.51K | 407.37K |
| Common Stock Indirect | 8/8/2023 | P · Purchase | +68.43K | $12.00 | $820.89K | 4.6% | 1.50M | 1.57M |
| Common Stock Indirect | 8/8/2023 | P · Purchase | +18.63K | $12.00 | $223.44K | 4.6% | 407.37K | 426K |
| Total | +221.55K | $2.66M | ||||||
Derivative Transactions0
No derivative transactions reported